Komori
Earnings5619MRSO.,IncInformation and Communications, Services and Others

Summary of Financial Results for the First Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)

In the first quarter, net sales increased 3.6% year on year, while operating, ordinary and net losses all narrowed from the same period of the previous year. However, the Company remained in the red at every profit level.

Worth reading
42Recurring
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
3.6
% (year-on-year change in revenue)
Wording
Conditional
How definitive the wording is.

Results for this period

First quarter1 January 2026–31 March 2026ConsolidatedJapanese GAAP
Net Sales291¥ millionYear on year +3.6%Progress 23.1%
Operating profit-10¥ million
Ordinary income-8¥ million
Net income attributable to owners of the parent-5¥ million

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥(1.45)
Financial position at period-end
Total assets2,157¥ million
of which net assets 1,944 ¥ millionEquity ratio 90.1%vs. prior year-end -2.0pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥1,262 million (YoY +17.1%)
Operating profit¥-76 million
Ordinary income¥-75 million
Net income¥-76 million
Annual Dividend Forecast¥0 → ¥0(0.0%)
Factors Behind Changes in Business Performance

Steady growth in demand for medical checkups, expansion of the number of listed medical facilities and corporate bookings, and initiatives to expand use of the advertising services.

Disclosure regarding the going concern assumption

No applicable matters

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 Yes見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Name of newly added company Not disclosed / Excluded 0 / Excluded Company Name Not disclosed
Depreciation and amortization¥175 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingNo
Issued Shares at Period-End3,552,750
Treasury Shares at Period-End44,272
Results for this period
ItemDetails
Fiscal Period ClassificationFirst quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 January 2026–31 March 2026
Net Sales¥291 million (YoY +3.6%)
Operating profit¥-10 million
Ordinary income¥-8 million
Profit attributable to owners of the parent¥-5 million
Net income per share¥(1.45)
Equity ratioEnd of the current fiscal period 90.1 / End of previous period 92.1
Total assets¥2,157 million
Net assets¥1,944 million
Full-year earnings forecastNet Sales ¥1,262 million (YoY +17.1%) / Operating profit ¥-76 million / Ordinary income ¥-75 million / Net income ¥-76 million
Annual Dividend Forecast¥0 → ¥0(0.0%)
Depreciation and amortization¥175 thousand
Disclosure regarding the going concern assumptionNo applicable matters
Change in accounting policyChanges due to revisions to standards No / Other changes Yes / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 / Name of newly added company Not disclosed / Excluded 0 / Excluded Company Name Not disclosed
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingNo
Issued Shares at Period-End3,552,750
Treasury Shares at Period-End44,272
Factors Behind Changes in Business PerformanceSteady growth in demand for medical checkups, expansion of the number of listed medical facilities and corporate bookings, and initiatives to expand use of the advertising services.
Items this document does not state (15)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossBreakdown of extraordinary income (loss)Material subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In addition to steady growth in demand for medical checkups, the Company worked to expand the number of listed medical facilities and corporate bookings through ongoing sales activities. In its advertising services, the Company increased medical-facility exposure and pursued promotions through partnerships with companies.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the First Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated) | MRSO.,Inc (5619) timely disclosure | Komori